PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Roche

Roche

RocheHeadquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totalled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at www.roche.com.

Roche RSS Channel

Filters
List of articles in category Roche
Title Published Date
Roche launches Institute of Human Biology to accelerate breakthroughs in R&D by unlocking the potential of human model systems 08 May 2023
Roche announces donation of essential medicines and diagnostic solutions to the people affected by the devastating earthquake in Türkiye and Syria 15 February 2023
Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above 20 January 2023
Roche develops unique PCR tests to detect the monkeypox virus 27 May 2022
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure 17 May 2022
Roche donates additional medicines and diagnostics for Ukraine 30 March 2022
Roche announces donation of essential medicines to Ukraine 02 March 2022
WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19 14 February 2022
Roche completed the repurchase of Roche shares from Novartis 06 December 2021
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease 11 November 2021
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research 26 October 2021
Roche's anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer's disease 14 October 2021
Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load in patients hospitalised with COVID-19 30 September 2021
Roche opens access to pathology imaging tools to improve patient care 17 September 2021
European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia 25 May 2021
Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81% 12 April 2021
Roche announces the upcoming launch of the SARS-CoV-2 Rapid Antigen Test Nasal allowing for patient self-collection 05 February 2021
Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19 20 August 2020
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia 28 May 2020
Roche response to COVID-19 pandemic 26 March 2020

Page 1 of 6

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
  1. You are here:  
  2. Home
  3. Roche

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2025 PharmaNews.eu. All Rights Reserved.